Khoury R M, Katz P O, Hammod R, Castell D O
Department of Medicine, The Graduate Hospital, Philadelphia, Pennsylvania 19146, USA.
Aliment Pharmacol Ther. 1999 May;13(5):675-8. doi: 10.1046/j.1365-2036.1999.00499.x.
We have previously shown that 70% of patients experience nocturnal gastric acid breakthrough (defined as pH<4 for more than 60 min between 22.00 and 06.00 hours) on twice a day (b.d.) proton pump inhibitor. Adding 150 or 300 mg of ranitidine at bedtime is more effective than additional omeprazole at bedtime in control of night-time acid breakthrough.
To assess whether omeprazole 20 mg AM plus ranitidine 150 mg HS would be as effective as omeprazole 20 mg before breakfast and dinner (b.d. AC) in intragastric pH control, particularly during the overnight period.
Twenty healthy volunteers (11 males, 9 females, mean age 32.7 years) were treated with omeprazole (OME) 20 mg b.d. AC and placebo HS or omeprazole 20 mg AM and placebo before dinner plus ranitidine (RAN) 150 mg HS for 7 days, in a randomized, double-blind, crossover design, with a 1 week washout between study periods. On day 8 subjects were monitored for 24 h with a single channel pH probe placed in the stomach 10 cm below the proximal border of the LES. Percentage time pH<4 for total, upright and recumbent positions were compared between the two regimens using Wilcoxon matched pairs testing.
Expressed in median values of percentage time pH<4: upright time intragastric pH<4 on OME 20 mg b.d. AC was 18.9 compared to 29.7 on OME AM + RAN HS (P = 0.003). Recumbent time pH<4 on OME 20 mg b.d. AC was 23.45 compared to 44.75 on OME AM + RAN HS (P = 0.02).
Bedtime ranitidine does not eliminate the need for an evening dose of omeprazole to control intragastric pH in patients requiring more than a single daily dose of omeprazole.
我们之前已经表明,70%的患者在每日两次服用质子泵抑制剂时会出现夜间胃酸突破(定义为在22:00至06:00之间pH值<4超过60分钟)。睡前加用150毫克或300毫克雷尼替丁在控制夜间胃酸突破方面比睡前加用额外的奥美拉唑更有效。
评估晨起服用20毫克奥美拉唑加睡前服用150毫克雷尼替丁在控制胃内pH值方面,尤其是在夜间期间,是否与早餐和晚餐前(每日两次)服用20毫克奥美拉唑一样有效。
20名健康志愿者(11名男性,9名女性,平均年龄32.7岁)采用随机、双盲、交叉设计,接受每日两次早餐和晚餐前服用20毫克奥美拉唑及睡前服用安慰剂,或晨起服用20毫克奥美拉唑、晚餐前服用安慰剂加睡前服用150毫克雷尼替丁治疗7天,两个研究阶段之间有1周的洗脱期。在第8天,使用置于LES近端边界下方10厘米处胃内的单通道pH探头对受试者进行24小时监测。使用Wilcoxon配对检验比较两种治疗方案在总时间、直立位和卧位时pH<4的时间百分比。
以pH<4时间百分比的中位数表示:每日两次早餐和晚餐前服用20毫克奥美拉唑时直立位胃内pH<4的时间为18.9%,而晨起服用奥美拉唑加睡前服用雷尼替丁时为29.7%(P = 0.003)。每日两次早餐和晚餐前服用20毫克奥美拉唑时卧位pH<4的时间为23.45%,而晨起服用奥美拉唑加睡前服用雷尼替丁时为44.75%(P = 0.02)。
对于需要每日服用超过一剂奥美拉唑的患者,睡前服用雷尼替丁并不能消除晚间服用奥美拉唑以控制胃内pH值的必要性。